A Multicenter Prospective Real-world Study on Bisphosphonates Targeting Triple-negative Breast Cancer
Latest Information Update: 05 Jul 2023
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Advanced breast cancer; Triple negative breast cancer
- Focus Therapeutic Use
Most Recent Events
- 13 Oct 2019 Status changed from not yet recruiting to recruiting.
- 07 Aug 2019 New trial record